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(in past four weeks, yes/no), and comorbid diagnosis of sub-
stance use disorder (yes/no). RESULTS: The average annual
mental health cost was highest for patients who attempted
suicide (yes $46,024, no $15,865), followed by patients with
psychiatric hospitalization in the past six months (yes $37,329,
no $12,229), patients with arrests (yes $31,081, no $15,655),
prior violent behaviors (yes $18,778, no $16,113), and those
with comorbid substance use disorder (yes $19,034, no
$15,038). CONCLUSIONS: Crisis-prone patients, particularly
those with a recent suicide attempt or psychiatric hospitalization
tend to incur substantial mental health costs. Findings also
suggest that patients who are involved in the criminal justice
system also accrue high costs within the mental health delivery
system.
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OBJECTIVE: To examine the longitudinal relationship between
depression outcomes and subsequent functional disability (FD)
in the non-institutionalized elderly. METHODS: Secondary data
analysis was performed using the population-based Assets and
Health Dynamics of the Oldest Old (AHEAD) cohort (age ≥70
years). Depression was considered present if four or more depres-
sive symptoms were reported on the modiﬁed Center for Epi-
demiological Studies-Depression Scale (CES-D). CES-D scores
from baseline, two-year and ﬁve-year follow-up allowed the
characterization of seven distinct patterns of depression (plus
never depressed): remittent, endogenous, emergent, remitting
persistent, recurrent, emerging persistent and persistent. FD was
operationalized as the ability to perform six activities of daily
living (ADL) and ﬁve instrumental ADL. The subsequent impact
of depression patterns on FD scores (at two, ﬁve and seven-year
follow-up) over time was analyzed using mixed-effect regression
models. RESULTS: Of the 8222 initial respondents, 57% were
considered ineligible. Among the remaining 3476 respondents,
half were never depressed. Pattern-based FD mean (SD) scores
were: remittent 1.4 (2.4) (n = 166); endogenous, 1.4 (2.2) (n =
136); recurrent, 2.03 (2.6) (n = 63); emergent 1.2 (2.2) (n = 332);
remittent persistent 1.9 (2.5) (n = 64); recurrent 2.0 (2.6) (n =
103); emerging persistent 2.1 (2.6) (n = 108) and persistent 2.1
(2.5) (n = 144). After adjusting for age, gender, and comorbid-
ity, and baseline FD, all patterns had signiﬁcantly more FD than
those never depressed, with the exception of the remittent
pattern. Compared to an emergent pattern, emerging persistent
(difference = 0.69 (0.19), p < 0.001) and persistent pattern (dif-
ference = 0.49 (0.15), p < 0.001) had higher mean FD over time.
CONCLUSIONS: The elderly with depression have more FD
compared to those never depressed, but FD can improve with
the remission of depression. Important differences in FD scores
between depression patterns were observed (i.e. effect sizes >0.5),
providing health outcomes-based support for a pattern-based
classiﬁcation of longitudinal depression.
MH4
EFFECT OF SECOND-GENERATION ANTIDEPRESSANT
DISCONTINUATION ON DEPRESSIVE RELAPSE IN ADULT
PATIENTS WITH BIPOLAR DEPRESSION
Fu AZ, Christensen DB, Hansen RA
University of North Carolina, Chapel Hill, NC, USA
OBJECTIVES: There are almost no data addressing antidepres-
sant’s long-term prophylaxis use that both establishes the mood
stability and delays depressive episodes in patients with bipolar
disorder. This study concentrated on the question that whether
patients who continued taking antidepressant beyond 6 months
after depressive remission are less likely to have depressive
relapse than patients who discontinued early, with a focus 
on modern second-generation antidepressant medications.
METHODS: A total of 589 bipolar subjects were identiﬁed with
interested antidepressant use after a depressive remission, fol-
lowed by at least 6-months of continuous enrollment in a
national managed care plan between January 1998 and Decem-
ber 2002. Duration of pharmacotherapy was deﬁned based on
the computerized diagnosis and pharmacy records. A Cox pro-
portional hazard model was developed to predict time from
depressive remission to next depressive relapse with continuous
antidepressant use either longer or shorter than 6 months.
Propensity score method with greedy matching was employed in
addition to further balance the observed background covariates
and baseline disease severity between comparison groups.
RESULTS: The Kaplan-Meier estimate of the sample from
propensity score matching showed that time to 50% survival
with continuation and discontinuation groups were 16.5 months
and 6.8 months respectively. The log-rank homogeneity test of
survival curves indicated a signiﬁcant difference (p < 0.05). The
Cox model identiﬁed a signiﬁcantly lower risk of depressive
relapse among those who continued antidepressant treatment
beyond 6 months after remission than those who discontinued
treatment within 6 months, with a statistically signiﬁcant hazard
ratio of 0.61 (95% CI: 0.42–0.88). CONCLUSIONS: This study
suggests the potential adverse outcome of removing an antide-
pressant treatment after depressive remission in patients with
bipolar disorder. Given the concerns regarding a risk of switch-
ing into mania by antidepressant use, an optimal prophylaxis
treatment after depressive remission should balance risks
between depressive relapse and manic switch.
